Viral inactivation of human platelet lysate by gamma irradiation preserves its optimal efficiency in the expansion of human bone marrow mesenchymal stromal cells
S Viau, S Eap, L Chabrand, A Lagrange… - Transfusion, 2019 - Wiley Online Library
BACKGROUND Human platelet lysate (hPL) represents a powerful medium supplement for
human mesenchymal stromal cell (hMSC) expansion. The recently published general …
human mesenchymal stromal cell (hMSC) expansion. The recently published general …
Effects of amotosalen treatment on human platelet lysate bioactivity: A proof-of-concept study
Background Clinical application of mesenchymal stromal cells (MSCs) usually requires an in
vitro expansion step to reach clinically relevant numbers. In vitro cell expansion necessitates …
vitro expansion step to reach clinically relevant numbers. In vitro cell expansion necessitates …
Allogenic Pure Platelet-Rich Plasma Therapy for Rotator Cuff Disease: A Bench and Bed Study
J Magalon, M Velier, M Vogtensperger… - American Journal of …, 2019 - search.ebscohost.com
The authors discuss a study about allogenic pure platelet-rich plasma therapy for rotator cuff
disease. Study highlights include the use of autologous PRP for treatment of …
disease. Study highlights include the use of autologous PRP for treatment of …
Effects of amotosalen treatment on human platelet lysate bioactivity
Background Clinical application of mesenchymal stromal cells (MSCs) usually requires an in
vitro expansion step to reach clinically relevant numbers. In vitro cell expansion necessitates …
vitro expansion step to reach clinically relevant numbers. In vitro cell expansion necessitates …
The effect of amotosalen treatment on human platelet lysate bioactivity: Effects on proliferation and tri-lineage differentiation of mesenchymal stromal cells
C Christensen - skemman.is
Mesenchymal stromal cells (MSCs) have become a subject of increased scientific interest in
the past years due to their clinical potential. Cell-based therapies utilize the ability of MSCs …
the past years due to their clinical potential. Cell-based therapies utilize the ability of MSCs …